Mats Hellström Selected Research

Mats Hellström Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 04/2011
8	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2016
4	Infertility (Sterility) 05/2021 - 07/2017
2	Pathologic Complete Response 01/2021 - 01/2018
2	Infections 01/2020 - 03/2015
2	Reperfusion Injury 01/2019 - 01/2017
2	Ischemia 01/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2011
2	Wounds and Injuries (Trauma) 11/2014 - 07/2008
2	Alzheimer Disease (Alzheimer's Disease) 04/2011 - 02/2007
1	Primary Ovarian Insufficiency 11/2022
1	Adenomyosis 11/2022
1	Polyps 11/2022
1	Endometriosis 11/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2022
1	Gynatresia 11/2022
1	Leiomyoma (Uterine Fibroids) 11/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Fatigue 05/2020
1	Leukopenia 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Neutropenia 01/2020
1	Febrile Neutropenia 01/2020
1	Typhlitis 11/2018
1	Atopic Dermatitis (Atopic Eczema) 03/2017
1	Dermatitis 03/2017
1	Neuroinflammatory Diseases 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016
1	Ganglion Cysts (Ganglion) 01/2016
1	Edema (Dropsy) 03/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Optic Nerve Injuries 12/2011

Drug/Important Bio-Agent (IBA)

5	Docetaxel (Taxotere)FDA Link 01/2021 - 01/2018
3	Hormones (Hormone)IBA 01/2021 - 11/2016
3	Epirubicin (Ellence)FDA LinkGeneric 05/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 03/2017 - 04/2011
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2020 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 05/2020 - 01/2020
2	EnzymesIBA 11/2018 - 04/2011
2	Gamma Secretase Inhibitors and ModulatorsIBA 04/2011 - 02/2007
1	Biocompatible Materials (Biomaterials)IBA 11/2022
1	HydrogelsIBA 11/2022
1	AntigensIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	pertuzumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	vinflunineIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ChromatinIBA 11/2017
1	Histones (Histone)IBA 11/2017
1	Lysine (L-Lysine)FDA Link 11/2017
1	NucleotidesIBA 11/2017
1	TECAIBA 03/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2017
1	phthalic anhydrideIBA 03/2017
1	punicalaginIBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	SB 203580IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Apoptosis Regulatory ProteinsIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Pharmaceutical PreparationsIBA 12/2016
1	fludarabineIBA 12/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 03/2015
1	ClaudinsIBA 03/2015
1	Tight Junction ProteinsIBA 03/2015
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2014
1	Nerve Growth Factors (Neurotrophins)IBA 01/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2008

Therapy/Procedure

7	Transplantation 05/2021 - 03/2015
5	Drug Therapy (Chemotherapy) 05/2020 - 12/2011
5	Adjuvant Chemotherapy 05/2020 - 11/2016
3	Neoadjuvant Therapy 01/2021 - 01/2018
2	Therapeutics 01/2021 - 05/2020
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Immunotherapy 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 04/2018